Research and Markets: Generic and Innovative Drugs Market in CIS Countries 2013 – Russia, Ukraine and Kazakhstan

Posted: Published on May 13th, 2013

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ph8js4/generic_and) has announced the addition of the "Generic and Innovative Drugs Market in CIS Countries 2013 - Russia, Ukraine and Kazakhstan" report to their offering.

Keep current with the changing CIS generic and innovative drug segments.

Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015.

Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile, the effects of programmes such as Russia's Pharma 2020, Kazakhstan's GMP initiative and Ukraine's updated reimbursement structure are visible in the marketplace.

How will issues like these influence market development in the next few years? How will they change pricing structures and reimbursement schemes? What are the rules regarding data exclusivity periods and drug patent viability?

Stay informed with regard to these topics and many more by reviewing Generic and innovative drugs market in CIS countries 2013, Russia, Ukraine and Kazakhstan, Development forecasts for 2013-2015. This authoritative report is a single and complete source of market data, analysis and forecasts, combined to serve the needs of professionals with interests in the market.

This PMR publication includes all relevant data concerning the size and value of the generic and innovative drugs markets in Russia, Ukraine and Kazakhstan. The document enables users to perform comparative analysis of market conditions in each country quickly and simply. It provides market share data for these drug segments in each of the three countries, highlights the top selling products, and profiles the companies that lead the region in production and sale of generic and innovative preparations. The report takes a look at the future of the markets, predicting the effects of trends and regulatory actions on growth and development in carefully constructed forecasts that span the period 2013-2015.

Key Topics Covered:

I. Methodology

Read more:
Research and Markets: Generic and Innovative Drugs Market in CIS Countries 2013 - Russia, Ukraine and Kazakhstan

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.